Home
About Us
Our Team
Our Story
Mission and Vision
What is MAOD
About MAO-D
Genetics of MAO-D
Variants of MAO-D
Treatment Options
Scientific References
Our Goals
Research Initiatives
Participation by MAOD Families
Frequency of MAOD
Outreach Efforts
Updates
Gene Therapy Program
Selection of Potential Drug Candidates
Preclinical Testing of Promising Drug Leads
Generation of Patient-Derived iPSCs
CLIA-Compliant Serotonin Test for MAOD Patients
ODD Approval of MAOD by FDA
Contact Us
Donate
Menu
Menu
Jean C. Shih, PhD
Mariano Garcia-Blanco, MD, PhD
Han Brunner, MD
Marco Bortolato, MD, PhD
Scroll to top
Scroll to top
Scroll to top
